BlackRock’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $784M | Sell |
|
|||||
|
2025
Q1 | $594M | Sell |
|
|||||
|
2024
Q4 | $599M | Sell |
|
|||||
|
2024
Q3 | $659M | Buy |
|
|||||
|
2024
Q2 | $716M | Buy |
|
|||||
|
2024
Q1 | $612M | Sell |
|
|||||
|
2023
Q4 | $607M | Sell |
|
|||||
|
2023
Q3 | $331M | Buy |
|
|||||
|
2023
Q2 | $413M | Sell |
|
|||||
|
2023
Q1 | $298M | Buy |
|
|||||
|
2022
Q4 | $275M | Buy |
|
|||||
|
2022
Q3 | $379M | Buy |
|
|||||
|
2022
Q2 | $267M | Sell |
|
|||||
|
2022
Q1 | $344M | Buy |
|
|||||
|
2021
Q4 | $572M | Buy |
|
|||||
|
2021
Q3 | $534M | Buy |
|
|||||
|
2021
Q2 | $456M | Buy |
|
|||||
|
2021
Q1 | $490M | Sell |
|
|||||
|
2020
Q4 | $567M | Buy |
|
|||||
|
2020
Q3 | $444M | Sell |
|
|||||
|
2020
Q2 | $385M | Buy |
|
|||||
|
2020
Q1 | $274M | Buy |
|
|||||
|
2019
Q4 | $341M | Sell |
|
|||||
|
2019
Q3 | $316M | Buy |
|
|||||
|
2019
Q2 | $388M | Buy |
|
|||||
|
2019
Q1 | $272M | Sell |
|
|||||
|
2018
Q4 | $186M | Sell |
|
|||||
|
2018
Q3 | $269M | Buy |
|
|||||
|
2018
Q2 | $211M | Buy |
|
|||||
|
2018
Q1 | $299M | Buy |
|
|||||
|
2017
Q4 | $232M | Buy |
|
|||||
|
2017
Q3 | $208M | Buy |
|
|||||
|
2017
Q2 | $145M | Buy |
|
|||||
|
2017
Q1 | $82.1M | Buy |
|
|||||
|
2016
Q4 | $55K | Buy |
|
|||||
|
2016
Q3 | $59K | Buy |
|
|||||
|
2016
Q2 | $26K | Buy |
|
|||||
|
2016
Q1 | $11K | Buy |
|
|||||
|
2015
Q4 | $6K | Hold |
|
|||||
|
2015
Q3 | $5K | Hold |
|
|||||
|
2015
Q2 | $6K | Buy |
|